Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

211 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Approach to acute exacerbation of idiopathic pulmonary fibrosis.
Bhatti H, Girdhar A, Usman F, Cury J, Bajwa A. Bhatti H, et al. Ann Thorac Med. 2013 Apr;8(2):71-7. doi: 10.4103/1817-1737.109815. Ann Thorac Med. 2013. PMID: 23741267 Free PMC article.
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia with a median survival of 3 years after diagnosis. Acute exacerbation of IPF (AE-IPF) is now identified as a life-threatening complication. ...Most of the patients are managed in a
Idiopathic pulmonary fibrosis (IPF) is a chronic interstitial pneumonia with a median survival of 3 years after diagnosis. Acu …
Pulmonary Hypertension Secondary to COPD.
Shujaat A, Bajwa AA, Cury JD. Shujaat A, et al. Pulm Med. 2012;2012:203952. doi: 10.1155/2012/203952. Epub 2012 Aug 29. Pulm Med. 2012. PMID: 22973510 Free PMC article.
Use of endobronchial ultrasound to evaluate nonthrombotic endovascular lesions in pulmonary arteries: a systematic review.
Al-Saffar F, Ibrahim S, Seeram V, Bajwa AA, Shujaat A. Al-Saffar F, et al. J Bronchology Interv Pulmonol. 2015 Jan;22(1):28-32. doi: 10.1097/LBR.0000000000000133. J Bronchology Interv Pulmonol. 2015. PMID: 25590480 Review.
BACKGROUND: The finding of a filling defect in a pulmonary artery (PA) sometimes raises the possibility of cancer. Endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration (TBNA) may confirm the underlying nature of the endovascular lesion. ...The can …
BACKGROUND: The finding of a filling defect in a pulmonary artery (PA) sometimes raises the possibility of cancer. Endobronchi …
Use of pulmonary arterial hypertension-specific therapy in non-WHO group I pulmonary hypertension.
Shujaat A, Bellardini J, Cury JD, Bajwa AA. Shujaat A, et al. South Med J. 2015 Jan;108(1):51-7. doi: 10.14423/SMJ.0000000000000217. South Med J. 2015. PMID: 25580759
METHODS: We performed a retrospective chart review of consecutive patients with non-World Health Organization group I PH treated with PAH-specific therapy. ...The 6-minute walk distance improved significantly for the whole group in an initial follow-up period of 4.6 (2.3) …
METHODS: We performed a retrospective chart review of consecutive patients with non-World Health Organization group I PH treated with …
Effect of PAH specific therapy on pulmonary hemodynamics and six-minute walk distance in portopulmonary hypertension: a systematic review and meta-analysis.
Faisal M, Siddiqi F, Alkaddour A, Bajwa AA, Shujaat A. Faisal M, et al. Pulm Med. 2014;2014:528783. doi: 10.1155/2014/528783. Epub 2014 Nov 16. Pulm Med. 2014. PMID: 25478223 Free PMC article. Review.
None was a RCT. The baseline mPAP was 48.6 ± 4.4 mmHg, cardiac output (CO) 5.6 ± 0.9 L/min, and pulmonary vascular resistance (PVR) 668.6 ± 219.1 dynes.sec/cm(5). ...
None was a RCT. The baseline mPAP was 48.6 ± 4.4 mmHg, cardiac output (CO) 5.6 ± 0.9 L/min, and pulmonary vascular resistance (PVR) 6 …
Use of pulmonary arterial hypertension-specific therapy in overweight or obese patients with obstructive sleep apnea and pulmonary hypertension.
Shujaat A, Bellardini J, Girdhar A, Bajwa AA. Shujaat A, et al. Pulm Circ. 2014 Jun;4(2):244-9. doi: 10.1086/675987. Pulm Circ. 2014. PMID: 25006443 Free PMC article.
We performed a retrospective review of overweight or obese patients with OSA and PH who were treated with PAH-specific therapy in our PH clinic. ...PH was treated with an endothelin receptor antagonist (n = 8) or a phosphodiesterase-5 inhibitor (n = 3). The 6-minute …
We performed a retrospective review of overweight or obese patients with OSA and PH who were treated with PAH-specific therapy in our …
Diagnostic accuracy of echocardiography combined with chest CT in pulmonary hypertension.
Shujaat A, Bajwa AA, Al-Saffar F, Bellardini J, Jones L, Cury JD. Shujaat A, et al. Clin Respir J. 2018 Mar;12(3):948-952. doi: 10.1111/crj.12610. Epub 2017 Feb 3. Clin Respir J. 2018. PMID: 28063199
It is possible that a combination of the two may offer a better way of identifying pulmonary hypertension (PH) than either one alone. ...RESULTS: There was a total of 87 patients. The mean ± SD age was 54.3 ± 15.9 years and 69 (79%) were female. The prevalenc …
It is possible that a combination of the two may offer a better way of identifying pulmonary hypertension (PH) than either one …
Proton therapy for lung cancer.
Nichols RC Jr, Henderson RH, Huh S, Flampouri S, Li Z, Bajwa AA, D'Agostino HJ, Pham DC, Mendenhall NP, Hoppe BS. Nichols RC Jr, et al. Thorac Cancer. 2012 May;3(2):109-116. doi: 10.1111/j.1759-7714.2011.00098.x. Thorac Cancer. 2012. PMID: 28920285 Review.
Since charged particles, such as protons, have a penetration length that can be modified by using different energies, protons offer the clinician the ability to modulate radiation dose deposition along the beam path. ...
Since charged particles, such as protons, have a penetration length that can be modified by using different energies, protons offer t …
Operator dependent factors implicated in failure of non-invasive positive pressure ventilation (NIPPV) for respiratory failure.
Bhatti H, Ramdass A, Cury JD, Jones LM, Shujaat A, Louis M, Seeram V, Bajwa AA. Bhatti H, et al. Clin Respir J. 2017 Nov;11(6):901-905. doi: 10.1111/crj.12434. Epub 2016 Jan 6. Clin Respir J. 2017. PMID: 26663322
METHOD: After institutional board review approval a retrospective chart review was performed of consecutive patients who were initiated on and failed NIPPV between January 2009 and December 2009. Data was recorded regarding baseline demographics, admission diagnosis, indic …
METHOD: After institutional board review approval a retrospective chart review was performed of consecutive patients who were initiat …
Management of infectious processes of the pleural space: a review.
Girdhar A, Shujaat A, Bajwa A. Girdhar A, et al. Pulm Med. 2012;2012:816502. doi: 10.1155/2012/816502. Epub 2012 Mar 14. Pulm Med. 2012. PMID: 22536502 Free PMC article.
This calls for employment of advanced treatment modalities and development of a standardized protocol to manage pleural sepsis early. ...
This calls for employment of advanced treatment modalities and development of a standardized protocol to manage pleural sepsis early. …
211 results
Jump to page
Feedback